We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-14.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.1B
AUM Growth
-$2.86B
Cap. Flow
-$262M
Cap. Flow %
-2%
Top 10 Hldgs %
37.9%
Holding
1,479
New
56
Increased
646
Reduced
399
Closed
58

Top Buys

Rank Stock Value
1
MAA icon
Mid-America Apartment Communities
MAA
+$174M
2
EQIX icon
Equinix
EQIX
+$83.3M
3
DLR icon
Digital Realty Trust
DLR
+$82.9M
4
PLD icon
Prologis
PLD
+$52.3M
5
INVH icon
Invitation Homes
INVH
+$39.6M

Top Sells

Rank Stock Value
1
AMT icon
American Tower
AMT
+$263M
2
VICI icon
VICI Properties
VICI
+$230M
3
ESS icon
Essex Property Trust
ESS
+$96.1M
4
VTR icon
Ventas
VTR
+$61.2M
5
EBIZ icon
Global X E-commerce ETF
EBIZ
+$39.2M

Sector Composition

Rank Sector Weight
1 Real Estate 60.75%
2 Technology 8.8%
3 Healthcare 4.18%
4 Consumer Discretionary 3.61%
5 Financials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XNCR icon
1126
Xencor
XNCR
$1.43B
$6K ﹤0.01%
222
+51
+30% +$1.26K
ZNTL icon
1127
Zentalis Pharmaceuticals
ZNTL
$326M
$6K ﹤0.01%
212
+80
+61% +$2.12K
PEI
1128
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$6K ﹤0.01%
1,684
-101
-6% -$665
AGIO icon
1129
Agios Pharmaceuticals
AGIO
$2.15B
$5K ﹤0.01%
204
+46
+29% +$1.04K
AUPH icon
1130
Aurinia Pharmaceuticals
AUPH
$1.96B
$5K ﹤0.01%
528
+150
+40% +$1.68K
AXSM icon
1131
Axsome Therapeutics
AXSM
$12.3B
$5K ﹤0.01%
129
– –
BBIO icon
1132
BridgeBio Pharma
BBIO
$16.5B
$5K ﹤0.01%
550
+121
+28% +$1.01K
GRFS
1133
Grifois
GRFS
$5.42B
$5K ﹤0.01%
398
– –
MYGN icon
1134
Myriad Genetics
MYGN
$502M
$5K ﹤0.01%
267
– –
RVMD icon
1135
Revolution Medicines
RVMD
$39.1B
$5K ﹤0.01%
277
+62
+29% +$1.21K
RY icon
1136
Royal Bank of Canada
RY
$293B
$5K ﹤0.01%
50
-45
-47% -$4.6K
SUPN icon
1137
Supernus Pharmaceuticals
SUPN
$2.74B
$5K ﹤0.01%
182
– –
SWTX
1138
DELISTED
SpringWorks Therapeutics
SWTX
$5K ﹤0.01%
184
+40
+28% +$1.46K
TVTX icon
1139
Travere Therapeutics
TVTX
$5.18B
$5K ﹤0.01%
208
– –
VCYT icon
1140
Veracyte
VCYT
$4.47B
$5K ﹤0.01%
266
+59
+29% +$1.19K
ADPT icon
1141
Adaptive Biotechnologies
ADPT
$3.61B
$4K ﹤0.01%
530
+118
+29% +$1.04K
ARQT icon
1142
Arcutis Biotherapeutics
ARQT
$3.49B
$4K ﹤0.01%
172
– –
CRNX icon
1143
Crinetics Pharmaceuticals
CRNX
$8.89B
$4K ﹤0.01%
199
+67
+51% +$1.34K
GMAB icon
1144
Genmab
GMAB
$17.9B
$4K ﹤0.01%
137
– –
INVA icon
1145
Innoviva
INVA
$1.6B
$4K ﹤0.01%
260
+69
+36% +$1.13K
KURA icon
1146
Kura Oncology
KURA
$837M
$4K ﹤0.01%
227
– –
MDGL icon
1147
Madrigal Pharmaceuticals
MDGL
$12.5B
$4K ﹤0.01%
57
– –
PCVX icon
1148
Vaxcyte
PCVX
$8.03B
$4K ﹤0.01%
179
– –
PRTA icon
1149
Prothena Corp
PRTA
$442M
$4K ﹤0.01%
154
– –
RGNX icon
1150
Regenxbio
RGNX
$607M
$4K ﹤0.01%
146
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2022 Portfolio in Review

As of Q2 2022, Daiwa Securities Group held 1,479 positions worth $13.1B, down 18% from $16B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q2 2022 filing shows 56 new, 646 increased, 399 reduced and 58 closed positions. Its largest new stake was HDFC Bank: 143,030 shares worth $3.93M. The largest sale was American Tower, an estimated $263M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 60% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q2 2022 buy was HDFC Bank: 143,030 shares worth $3.93M.
  • Daiwa Securities Group added most to Mid-America Apartment Communities in Q2 2022, an estimated $174M increase.
  • Daiwa Securities Group's biggest Q2 2022 reduction was American Tower, cutting an estimated $263M.
  • Daiwa Securities Group fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $7.68M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13.1B portfolio in Q2 2022.
  • Daiwa Securities Group opened 56 new positions and closed 58 in Q2 2022.
  • Daiwa Securities Group's portfolio value fell 18% quarter-over-quarter to $13.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2022, filed 9 Aug 2022.